Use this phase to check tolerance
Table of Contents For people navigating GLP-1 medications like Ozempic, Wegovy, or Zepbound, this soup meets low appetite with warmth rather than pressure
According to NBC News, the third phase of the clinical trial found that people with osteoarthritis who dieted, exercised, and took semaglutide the blockbuster drug sold by Novo Nordisk as Ozempic and Wegovy lost more weight and reported a greater reduction in knee pain than those who lost weight with just diet and exercise. The study included roughly 400 patients with knee osteoarthritis, 80% being women, who experience osteoarthritis at higher rates than men, according to NBC News
That is a genetic-knockdown study in mice, not a drug trial: it tells you the target is real and metabolically meaningful in an animal model, but it does not test a drug, a dose, or a route